Sacha Gnjatic to Ipilimumab
This is a "connection" page, showing publications Sacha Gnjatic has written about Ipilimumab.
Connection Strength
0.223
-
Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med. 2018 12; 24(12):1845-1851.
Score: 0.181
-
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes. Eur Urol. 2018 05; 73(5):751-759.
Score: 0.042